Assignee
MANNKIND CORP
US·215 granted patents·98 pending applications·3,688 citations·filing 1998–2025
Top patents by PatentIndex Score
313 records- 0199US7820676B2Diketopiperazine salts for drug delivery and related methodsMANNKIND CORP·Filed 2005·Granted Oct 26, 2010·81 cites·13 claims
- 0298US9772216B2Powder dispensing and sensing apparatus and methodsMANNKIND CORP·Filed 2014·Granted Sep 26, 2017·43 cites·14 claims
- 0398US8778403B2Diketopiperazine microparticles with defined specific surface areasMANNKIND CORP·Filed 2013·Granted Jul 15, 2014·48 cites·20 claims
- 0498US8039431B2Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agentMANNKIND CORP·Filed 2007·Granted Oct 18, 2011·58 cites·16 claims
- 0598US7833550B2Dry powder formulations of antihistamine for nasal administrationMANNKIND CORP·Filed 2007·Granted Nov 16, 2010·40 cites·13 claims
- 0698US7799344B2Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agentsMANNKIND CORP·Filed 2006·Granted Sep 21, 2010·93 cites·18 claims
- 0798US6652885B2Purification and stabilization of peptide and protein pharmaceutical agentsMANNKIND CORP·Filed 2002·Granted Nov 25, 2003·171 cites·6 claims
- 0897US8372804B2Delivery of active agentsMANNKIND CORP·Filed 2008·Granted Feb 12, 2013·60 cites·21 claims
- 0997US7943178B2Methods and compositions for delivering peptidesMANNKIND CORP·Filed 2009·Granted May 17, 2011·60 cites·23 claims
- 1097US7836922B2Powder dispenser modules and powder dispensing methodsMANNKIND CORP·Filed 2006·Granted Nov 23, 2010·32 cites·21 claims
- 1197US7803404B2Method of drug formulation based on increasing the affinity of active agents for crystalline microparticle surfacesMANNKIND CORP·Filed 2006·Granted Sep 28, 2010·76 cites·25 claims
- 1297US7709639B2Catalysis of diketopiperazine synthesisMANNKIND CORP·Filed 2005·Granted May 4, 2010·68 cites·24 claims
- 1397US7648960B2Method for delivery of monomeric or dimeric insulin complexed to diketopiperazine microparticlesMANNKIND CORP·Filed 2003·Granted Jan 19, 2010·72 cites·11 claims
- 1497US6861234B1Method of epitope discoveryMANNKIND CORP·Filed 2000·Granted Mar 1, 2005·111 cites·19 claims
- 1596USD1011511SFluid delivery deviceMANNKIND CORP·Filed 2021·Granted Jan 16, 2024·3 cites·1 claims
- 1696US10870628B2Formation of N-protected 3,6-bis-(4-aminobutyl)-2,5-diketopiperazine through a cyclic α-N-protected amino esterMANNKIND CORP·Filed 2020·Granted Dec 22, 2020·3 cites·20 claims
- 1796US10620034B2Powder dispensing and sensing apparatus and methods for simultaneous filling of cartridgesMANNKIND CORP·Filed 2017·Granted Apr 14, 2020·10 cites·20 claims
- 1896US8377869B2Method of preventing adverse effects by GLP-1MANNKIND CORP·Filed 2008·Granted Feb 19, 2013·57 cites·20 claims
- 1996US7950423B2Powder transport systems and methodsMANNKIND CORP·Filed 2006·Granted May 31, 2011·23 cites·29 claims
- 2096US7794754B2Methods for fine powder formationMANNKIND CORP·Filed 2006·Granted Sep 14, 2010·39 cites·5 claims
- 2196US7364729B2Method of inducing a CTL responseMANNKIND CORP·Filed 2005·Granted Apr 29, 2008·28 cites·16 claims
- 2295US11345668B2Formation of N-protected 3,6-bis-(4-aminobutyl)-2,5-diketopiperazine through a cyclic α-N-protected amino esterMANNKIND CORP·Filed 2020·Granted May 31, 2022·2 cites·20 claims
- 2395US10577331B2Formation of N-protected 3,6-bis-(4-aminobutyl)-2,5-diketopiperazine through a cyclic alpha-N-protected amino ester intermediateMANNKIND CORP·Filed 2018·Granted Mar 3, 2020·5 cites·17 claims
- 2495US9944609B2Formation of N-protected bis-3,6-(4-aminobutyl)-2, 5-diketopiperazine through a cyclic alpha-N-protected amino esterMANNKIND CORP·Filed 2015·Granted Apr 17, 2018·6 cites·20 claims
- 2595US9187433B2Formation of N-protected 3,6-bis-(4-aminobutyl) -2, 5-diketopiperazine through a cyclic α-N-protected active amino ester intermediateMANNKIND CORP·Filed 2015·Granted Nov 17, 2015·8 cites·20 claims
- 2695US8962836B2Formation of N-protected bis-3,6-(4-aminobutyl)-2,5-diketopiperazine through a cyclic alpha-N-protected amino esterMANNKIND CORP·Filed 2014·Granted Feb 24, 2015·9 cites·14 claims
- 2795US7958916B2Powder dispensing and sensing apparatus and methodsMANNKIND CORP·Filed 2006·Granted Jun 14, 2011·20 cites·53 claims
- 2895USD605752SDry powder inhalerMANNKIND CORP·Filed 2008·Granted Dec 8, 2009·63 cites·1 claims
- 2995US6977074B2Method of inducing a CTL responseMANNKIND CORP·Filed 2001·Granted Dec 20, 2005·89 cites·32 claims
- 3095US6709844B1Avoidance of undesirable replication intermediates in plasmid propagationMANNKIND CORP·Filed 2000·Granted Mar 23, 2004·75 cites·22 claims
- 3194US12049453B2Formation of N-protected 3,6-bis-(4-aminobutyl)-2,5-diketopiperazine through a cyclic alpha-N-protected amino esterMANNKIND CORP·Filed 2022·Granted Jul 30, 2024·1 cites·20 claims
- 3294US10500159B2Apparatus and method for cryogranulating a pharmaceutical compositionMANNKIND CORP·Filed 2018·Granted Dec 10, 2019·6 cites·15 claims
- 3394US8909487B2Apparatus, system and method for measuring resistance of an inhalerMANNKIND CORP·Filed 2013·Granted Dec 9, 2014·43 cites·15 claims
- 3494USD635241SDry powder inhalerMANNKIND CORP·Filed 2008·Granted Mar 29, 2011·56 cites·1 claims
- 3594USD629887SDry powder inhalerMANNKIND CORP·Filed 2008·Granted Dec 28, 2010·59 cites·1 claims
- 3694USD629886SDry powder inhalerMANNKIND CORP·Filed 2008·Granted Dec 28, 2010·59 cites·1 claims
- 3794USD629888SDry powder inhalerMANNKIND CORP·Filed 2008·Granted Dec 28, 2010·54 cites·1 claims
- 3894USD629506SDry powder inhalerMANNKIND CORP·Filed 2008·Granted Dec 21, 2010·53 cites·1 claims
- 3994USD614760SDry powder inhalerMANNKIND CORP·Filed 2009·Granted Apr 27, 2010·59 cites·1 claims
- 4094USD613849SCartridge for a dry powder inhalerMANNKIND CORP·Filed 2009·Granted Apr 13, 2010·49 cites·1 claims
- 4194USD604833SDry powder inhalerMANNKIND CORP·Filed 2008·Granted Nov 24, 2009·54 cites·1 claims
- 4294USD597657SDry powder inhalerMANNKIND CORP·Filed 2008·Granted Aug 4, 2009·57 cites·1 claims
- 4394US7511119B2PRAME peptide analoguesMANNKIND CORP·Filed 2006·Granted Mar 31, 2009·12 cites·26 claims
- 4494US7305986B1Unit dose capsules for use in a dry powder inhalerMANNKIND CORP·Filed 2000·Granted Dec 11, 2007·175 cites·5 claims
- 4594US7278843B2Methods for fine powder formationMANNKIND CORP·Filed 2002·Granted Oct 9, 2007·39 cites·3 claims
- 4694US6991779B2Compositions for treatment or prevention of bioterrorismMANNKIND CORP·Filed 2003·Granted Jan 31, 2006·60 cites·15 claims
- 4794US2026042739A1Formation of N-Protected 3,6-bis-(4-aminoalkyl)-2,5,diketopiperazineMANNKIND CORP·Filed 2025·Application pending·0 cites
- 4894US2026027054A1Apparatus and method for cryogranulating a pharmaceutical compositionMANNKIND CORP·Filed 2025·Application pending·0 cites
- 4993US11479535B2Methods for the synthesis of activated ethylfumarates and their use as intermediatesMANNKIND CORP·Filed 2020·Granted Oct 25, 2022·2 cites·6 claims
- 5093US11185645B2Dry powder inhaler and system for drug deliveryMANNKIND CORP·Filed 2018·Granted Nov 30, 2021·2 cites·20 claims
Showing the top 50 of 313 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when MANNKIND CORP files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →